Oliver Luxxe Assets’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.11M Buy
38,325
+1,599
+4% +$297K 1.27% 16
2025
Q1
$7.69M Sell
36,726
-37,099
-50% -$7.77M 1.43% 12
2024
Q4
$13.8M Buy
73,825
+37,138
+101% +$6.96M 1.22% 14
2024
Q3
$7.24M Sell
36,687
-492
-1% -$97.2K 1.3% 10
2024
Q2
$6.38M Buy
37,179
+27
+0.1% +$4.63K 1.35% 17
2024
Q1
$6.77M Sell
37,152
-293
-0.8% -$53.4K 1.42% 14
2023
Q4
$5.8M Buy
37,445
+224
+0.6% +$34.7K 1.36% 19
2023
Q3
$5.55M Buy
37,221
+529
+1% +$78.9K 1.42% 17
2023
Q2
$4.94M Sell
36,692
-223
-0.6% -$30K 1.23% 25
2023
Q1
$5.88M Sell
36,915
-3,047
-8% -$486K 1.55% 11
2022
Q4
$6.46M Sell
39,962
-8
-0% -$1.29K 1.8% 7
2022
Q3
$5.36M Buy
39,970
+644
+2% +$86.4K 1.68% 9
2022
Q2
$6.02M Buy
39,326
+612
+2% +$93.7K 1.78% 5
2022
Q1
$6.28M Sell
38,714
-2,278
-6% -$369K 1.59% 7
2021
Q4
$5.55M Buy
40,992
+447
+1% +$60.5K 1.41% 11
2021
Q3
$4.37M Buy
40,545
+3,887
+11% +$419K 1.21% 19
2021
Q2
$4.13M Buy
36,658
+3,018
+9% +$340K 1.13% 22
2021
Q1
$3.64M Buy
33,640
+3,880
+13% +$420K 1.09% 29
2020
Q4
$3.24M Buy
29,760
+7,665
+35% +$836K 1.01% 33
2020
Q3
$1.94M Buy
22,095
+3,620
+20% +$317K 0.72% 52
2020
Q2
$1.81M Buy
18,475
+950
+5% +$93.3K 0.95% 46
2020
Q1
$1.38M Buy
+17,525
New +$1.38M 0.86% 47
2019
Q3
Sell
-31,583
Closed -$2.25M 115
2019
Q2
$2.25M Buy
31,583
+1,113
+4% +$79.3K 1.25% 40
2019
Q1
$2.46M Sell
30,470
-1,596
-5% -$129K 1.42% 28
2018
Q4
$2.96M Sell
32,066
-739
-2% -$68.1K 1.99% 17
2018
Q3
$3.1M Buy
32,805
+3,022
+10% +$285K 1.76% 23
2018
Q2
$2.82M Hold
29,783
1.79% 26
2018
Q1
$2.82M Buy
+29,783
New +$2.82M 1.74% 26